abrdn Healthcare Opportunities Fund 每股年股息為 2.16,收益率為 11.1327%。股息每 每月 支付,最後除權日為 Feb 20, 2026。
股息收益率
年度股息
除息日
11.1327%
$2.16
Feb 20, 2026
付款頻率
派息比例
每月
34.92%
股利歷史
除息日
現金金額
記錄日期
付款日
Feb 20, 2026
$0.18
Feb 20, 2026
Feb 27, 2026
Jan 23, 2026
$0.18
Jan 23, 2026
Jan 30, 2026
Dec 31, 2025
$0.18
Dec 31, 2025
Jan 12, 2026
Nov 21, 2025
$0.18
Nov 21, 2025
Nov 28, 2025
Oct 24, 2025
$0.18
Oct 24, 2025
Oct 31, 2025
Sep 23, 2025
$0.18
Sep 23, 2025
Sep 30, 2025
股利圖表
THQ 股利
THQ 股息增長(年增率)
Follow-Up Questions
abrdn Healthcare Opportunities Fund 當前的股息支付和年度股息是多少?
abrdn Healthcare Opportunities Fund 當前支付的股息為 $0.18。abrdn Healthcare Opportunities Fund 的年度股息為 $2.16
abrdn Healthcare Opportunities Fund 的股息支付比率是多少?
abrdn Healthcare Opportunities Fund 的股息支付比率為 34.92%
THQ 的除息日是什麼?
abrdn Healthcare Opportunities Fund 的除息日是 Feb 20, 2026。
abrdn Healthcare Opportunities Fund 多久支付一次股息?
每季。abrdn Healthcare Opportunities Fund 上次支付股息是在 Feb 27, 2026
關鍵數據
前收市價
$17.34
開盤價
$17.2
當日範圍
$17.05 - $17.42
52週區間
$15.14 - $20.5
交易量
54.8K
平均成交量
173.3K
股息收益率
11.13%
每股盈餘 (TTM)
-2.80
市值
$711.0M
什麼是 THQ?
abrdn Healthcare Opportunities Fund is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2014-07-25. abrdn Healthcare Opportunities Fund (the Fund) is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests primarily in equity and debt in securities of public and private United States (U.S.) and non-U.S. companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Fund will not invest more than 20%, as measured at the time of investment, in convertible securities. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. The company invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is abrdn Inc.